317358-61-5

Usage

Uses

Used in Organic Synthesis:
(3-BROMO-BENZYL)-METHYL-CARBAMIC ACID TERT-BUTYL ESTER is used as a reagent for its stable and non-reactive nature, facilitating various organic reactions.
Used in Pharmaceutical and Agrochemical Industries:
(3-BROMO-BENZYL)-METHYL-CARBAMIC ACID TERT-BUTYL ESTER is used as a precursor for the synthesis of various pharmaceuticals and agrochemicals, contributing to the development of new drugs and pesticides.
Used in Chemical Research and Development:
(3-BROMO-BENZYL)-METHYL-CARBAMIC ACID TERT-BUTYL ESTER is used as a key compound in advancing chemical research and development, exploring its potential applications and properties.

Upstream product

• 171663-13-1 t-butyl N-(3-bromobenzyl)carbamate 
• 74-88-4 methyl iodide 
• 706780-09-8 tert-butyl (4'-hydroxybiphenyl-3-ylmethyl)methylcarbamate 
• 24424-99-5 di-tert-butyl dicarbonate 
• 67344-77-8 1-(3-bromophenyl)-N-methylmethanamine 

Downstream Products

• 1350351-57-3 di-tert-butyl 3-((3-((tert-butoxycarbonyl(methyl)amino)methyl)phenyl)ethynyl)-5-(4-(isopropylsulfonyl)phenyl)pyrazin-2-yliminodicarbonate 
• 817618-31-8 tert-butyl methyl(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)carbamate 

Relevant academic research and scientific papers

COUMARIN-LIKE CYCLIC COMPOUND AS MEK INHIBITOR AND USE THEREOF

Disclosed are a class of coumarin-like cyclic compounds as MEK inhibitors and pharmaceutical compositions comprising the compounds, and the use of same in the preparation of a drug for treating MEK-related diseases. Particularly disclosed are compounds as shown in formula (I) and pharmaceutically acceptable salts thereof or tautomers thereof.

FUSED PYRAZOLE DERIVATIVES AS JAK INHIBITORS

Novel fused pyrazole derivatives of Formula (I) are disclosed; as well as process for their preparation, pharmaceutical compositions comprising them and their use in therapy as inhibitors of Janus Kinases (JAK).

COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE

The present invention relates to pyrazine and pyridine compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating various dis

NOVEL BIAROMATIC COMPOUNDS THAT MODULATE PPAR-RECEPTORS

Novel biaromatic compounds that modulate peroxisome proliferator-activator receptors, known as PPAR, having the formula (I): are formulated into pharmaceutical compositions useful in human or veterinary medicine, or alternatively, in cosmetic compositions.

NOVEL BIAROMATIC COMPOUNDS WHICH ACTIVATE RECEPTORS OF PPAR TYPE AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS

The invention relates to novel biaromatic compounds which correspond to the following general formula (I) and to their method of preparation and to their use in pharmaceutical compositions intended for use in human or veterinary medicine (in dermatology a

COMPOUNDS WHICH MODULATE PPARγ TYPE RECEPTORS, AND USE THEREOF IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS

The invention relates to novel compounds that correspond to the general formula (I) below and to a method for preparing them, and to their use in pharmaceutical compositions intended for use in human or veterinary medicine (in dermatology, and also in the field of cardiovascular diseases, immune diseases and/or diseases associated with lipid metabolism), or alternatively in cosmetic compositions.

NOVEL BIAROMATIC COMPOUNDS WHICH ACTIVATE PPAR? TYPE RECEPTORS, AND USE THEREOF IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS

The invention relates to novel biaromatic compounds that correspond to the general formula (I) below: and to a method for preparing them, and to their use in pharmaceutical compositions intended for use in human or veterinary medicine (in dermatology, and

Biaromatic ligand activators of PPARgamma receptors

Novel pharmaceutical/cosmetic compositions contain at least one biaromatic ligand activator of a PPARγ receptor, such biaromatic ligand having the structural formula (I): and are well suited, inter alia, for regulating and/or restoring skin lipid metabolism, for treating a wide variety of dermatological afflictions, and for preventing and/or treating the signs of aging and/or dry skin.